Guggenheim Securities Initiates Coverage on WRIGHT MEDICAL GROUP NV ORD(NASDAQ:WMGI). The shares have been rated Buy. The rating by Guggenheim Securities was issued on Jun 9, 2016.
In a different note, On May 5, 2016, Leerink Swann said it Maintains its rating on WRIGHT MEDICAL GROUP NV ORD. In the research note, the firm Raises the price-target to $24.00 per share. The shares have been rated ‘Outperform’ by the firm. On May 5, 2016, Wells Fargo said it Upgrades its rating on WRIGHT MEDICAL GROUP NV ORD. The shares have been rated ‘Outperform’ by the firm.
WRIGHT MEDICAL GROUP NV ORD (WMGI) made into the market gainers list on Wednesdays trading session with the shares advancing 1.16% or 0.21 points. Due to strong positive momentum, the stock ended at $18.32, which is also near the day’s high of $18.37. The stock began the session at $18.12 and the volume stood at 14,66,527 shares. The 52-week high of the shares is $26.78 and the 52 week low is $15.02. The company has a current market capitalization of $1,882 M and it has 10,27,13,374 shares in outstanding.
WRIGHT MEDICAL GROUP NV ORD(WMGI) last announced its earnings results on May 4, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $181.03M. Analysts had an estimated revenue of $171.01M. Earnings per share were $-0.06. Analysts had estimated an EPS of $-0.26.
Several Insider Transactions has been reported to the SEC. On Jun 3, 2016, Jennifer S. Walker (SVP, Process Improvement) sold 1,167 shares at $19.34 per share price.Also, On Jun 3, 2016, Terry Rich (President, Upper Extremities) sold 2,237 shares at $19.35 per share price.On Jun 3, 2016, Julie D Tracy (SVP & Chief Communic. Officer) sold 3,277 shares at $19.38 per share price, according to the Form-4 filing with the securities and exchange commission.
Wright Medical Group Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S. International and BioMimetic. The Company’s business includes products that are used in foot and ankle repair upper extremity products and biologics products which are used to replace damaged or diseased bone to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Company’s products include extremity hardware foot and ankle hardware upper extremity hardware and biologics.